Hematologic parameters are not predictors of upgrading or treatment in a racially diverse prospective study of men with prostate cancer on active surveillance.

Shelton, T Maxwell; Greenberg, Jacob W; Silberstein, Jonathan L; Krane, L Spencer

Shelton, T Maxwell; Greenberg, Jacob W; Silberstein, Jonathan L; Krane, L Spencer.

Affiliation

Shelton TM; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA.
Greenberg JW; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA.
Silberstein JL; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA.
Krane LS; Department of Urology, Tulane University School of Medicine, New Orleans, LA, USA.

Aging Male ; 23(5): 1400-1408, 2020 Dec.

Article in En | MEDLINE | ID: mdl-32500781

Subject(s)

Prostatic Neoplasms; Watchful Waiting; Humans; Lymphocytes; Male; Prognosis; Prospective Studies; Retrospective Studies

Key words

Active Surveillance; NLR; Neutrophil-to-lymphocyte ratio; PLR; Platelet-to-lymphocyte ratio; Prostate Cancer; Treatment Survival; Upgrading Survival

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Watchful Waiting Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans / Male Language: En Journal: Aging Male Journal subject: GERIATRIA Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google